Guangshengtang (300436.SZ): The II Phase Clinical Research Summary Report of the innovative Hepatitis B treatment drug GST-HG131.

Zhtng cijng APP xn, gung shng tng (300436.SZ) fb gnggo, gngs y gnzhng zhlio chungxn yo GST-HG131 y wnchng mn xng y xng gn yn II q lnghun shyn, bng y jnr hud II q lnghun shyn de ynji zngji bogo. Ynji jigu xinsh, GST-HG131 pin du mn xng y xng gn y hunhn hn y gn biogn HBsAg yu mngxin yzh xiogu, qi nqun xng lingho.